
A DEXA (Dual-Energy X-ray Absorptiometry) scan is a non-invasive medical imaging test that measures bone mineral density (BMD) using low-dose X-rays. Unlike conventional X-rays, DEXA technology employs two different energy beams to distinguish between bone and soft tissue, providing highly accurate assessments of bone health. The procedure is quick, painless, and typically focuses on the spine and hips—key areas vulnerable to fractures. In Hong Kong, where osteoporosis affects approximately 30% of postmenopausal women according to the Hong Kong Osteoporosis Foundation, DEXA scans serve as the gold standard for early detection of bone density loss. The term cr dexa scan often refers to the critical radiological interpretation of these results by specialists.
DEXA scans are primarily performed to diagnose osteoporosis, monitor treatment efficacy, and assess fracture risk. They are crucial for identifying osteopenia (low bone mass that may progress to osteoporosis) and determining overall skeletal health. Additionally, these scans are used to evaluate body composition—measuring fat and lean muscle mass—which is valuable for athletes and individuals with metabolic conditions. In clinical settings, DEXA helps guide decisions on medication, lifestyle interventions, and surgical planning for orthopedic patients.
Individuals who should consider a DEXA scan include postmenopausal women over 50, men over 70, and younger adults with risk factors such as family history of osteoporosis, prolonged steroid use, low body weight, or previous fractures. Hong Kong’s Hospital Authority recommends screening for women aged 65 and above, and younger postmenopausal women with additional risks. Those with conditions like hyperthyroidism, rheumatoid arthritis, or malabsorption syndromes (e.g., celiac disease) also benefit from periodic scans. For patients undergoing long-term corticosteroid therapy, a baseline cr dexa scan is advised within 3–6 months of starting treatment.
A DEXA report includes two primary scores: the T-score and Z-score. The T-score compares your bone density to that of a healthy young adult of the same sex, while the Z-score compares it to an average person of your age, gender, and ethnicity. The T-score is measured in standard deviations (SD) and categorizes bone health as follows:
A Z-score below -2.0 may indicate secondary causes of bone loss, such as nutritional deficiencies or underlying diseases, requiring further investigation.
These scores directly correlate with fracture risk. For instance, each 1.0 SD decrease in T-score doubles the fracture risk. In Hong Kong, studies show that over 20% of adults with osteopenia develop osteoporosis within a decade if untreated. The cr dexa scan interpretation also considers factors like scan quality, anatomical anomalies, and technical errors to ensure accuracy. For example, spinal arthritis might falsely elevate BMD readings, necessitating careful analysis by radiologists.
Bone density classifications guide clinical management. Osteopenia often warrants lifestyle changes and monitoring, while osteoporosis typically requires medication (e.g., bisphosphonates) and fall prevention strategies. Severe osteoporosis (T-score ≤ -2.5 with fractures) demands aggressive treatment. Hong Kong clinicians use FRAX® (a fracture risk assessment tool) alongside DEXA results to estimate 10-year probability of major osteoporotic fractures, incorporating local data for precision.
Age and gender significantly impact bone density. Women experience accelerated bone loss after menopause due to declining estrogen, with Hong Kong data indicating a 15–20% BMD reduction in the first five postmenopausal years. Men generally have higher peak bone mass but remain at risk after age 70. Ethnicity also plays a role; Asian populations, including Chinese in Hong Kong, have lower average BMD than Caucasians, increasing susceptibility to osteoporosis.
Lifestyle factors profoundly affect bone health:
Medical conditions like hyperparathyroidism, diabetes, and chronic kidney disease alter bone metabolism. Medications such as glucocorticoids, anticonvulsants, and proton pump inhibitors also reduce BMD. For accurate cr dexa scan assessment, clinicians must consider these variables to avoid misdiagnosis.
Discuss your DEXA report with a healthcare provider to interpret scores in context of your health history. In Hong Kong, public hospitals like Queen Mary Hospital offer osteoporosis clinics where specialists explain results and create personalized plans. Key discussion points include:
Treatment for low bone density combines pharmacotherapy and lifestyle interventions. First-line drugs include alendronate and zoledronic acid, which reduce fracture risk by 40–70%. For severe cases, teriparatide (a bone-building agent) may be prescribed. Hong Kong’s Department Health subsidizes certain treatments for eligible patients under the Samaritan Fund.
Lifestyle modifications are essential:
Regular follow-up with a cr dexa scan monitors progress and adjusts treatment as needed.
Yes, DEXA scans are extremely safe. The radiation exposure is very low—about 1/10th of a standard chest X-ray or equivalent to a day of natural background radiation. This makes it suitable for repeated use without significant risk. Pregnant women should avoid it unless absolutely necessary, as a precaution.
For individuals with normal bone density, rescreening every 2–5 years is sufficient. Those with osteopenia may need scans every 1–2 years, while osteoporosis patients on treatment typically undergo annual monitoring. Hong Kong guidelines recommend baseline scans at menopause for women and age 70 for men, with intervals tailored to initial results and risk factors.
While both use X-rays, DEXA scans are specialized for quantifying bone density with high precision, whereas conventional X-rays primarily detect fractures or structural abnormalities. DEXA’s dual-energy technology minimizes soft tissue interference, providing accurate BMD measurements. X-rays cannot diagnose osteoporosis until significant bone loss has occurred (≥30% density loss), making DEXA superior for early detection. The cr dexa scan report offers detailed numerical data, unlike qualitative X-ray assessments.